From August 24 to September 30, 2026, designated groups with influenza-like symptoms may receive publicly funded antivirals after a doctor's assessment, without paying for the medication.
Eligibility covers medical and disease-control personnel, long-term care workers and residents, childcare workers, elementary to senior high students, students in the first 3 years of 5-year junior colleges, household members or caregivers of high-risk patients, livestock and poultry disease-control workers, and personnel in crowded facilities such as military camps. No rapid flu test is required.
Influenza-like outpatient and emergency visits have risen slightly, with influenza A dominant. Severe cases and deaths are also increasing, mainly among people aged 65 or older and those with chronic diseases. More than 70% of severe cases were unvaccinated this season, while overseas positivity rates are rising or fluctuating.
Flu antivirals are not covered by National Health Insurance and can be costly. About 4,000 contracted medical institutions nationwide stock Tamiflu, Eraflu and other antivirals for doctors to prescribe based on clinical assessment.
Providers can be found on the Taiwan CDC website or the "Influenza and COVID-19 Vaccine and Flu Antiviral Map". Seek medical care promptly for shortness of breath, chest pain, cyanosis or altered consciousness. Handwashing, mask use and health monitoring are also advised as schools reopen.
